iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
- ISIN
- IE00BDZVHG35
- Base currency
- USD
- Currency hedged
- No
- Distributing
- Yes
- UCITS compliant
- Yes
- NAV as of 2022-06-28
- $5.44
- Annualized return rate
- 1.94% p.a. since inception
- Total NAV (USD)
- 35.9 million
- Total expense ratio
- 0.35%
Investment strategy
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
| Index | NASDAQ Biotechnology Index (Net Total Return) |
|---|---|
| Structure | Physical |
| Currency hedged | No |
| Inception date | 2018-03-05 |
| Use of income | Distributing |
|---|---|
| Distribution frequency | Semi-Annual |
| Domicile | Ireland |
Asset classes
| Name | % |
|---|---|
|
Equity
|
100% |
|
Cash
|
0% |
|
Cash Collateral and Margins
|
0% |
Sectors
| Name | % |
|---|---|
|
Health Care
|
100% |
|
Cash and/or Derivatives
|
0% |
Locations
| Name | % |
|---|---|
|
United States
|
88% |
|
United Kingdom
|
4% |
|
Germany
|
2% |
|
China
|
2% |
|
France
|
2% |
|
Belgium
|
1% |
|
Denmark
|
1% |
|
Canada
|
0% |
|
Spain
|
0% |
|
Ireland
|
0% |
|
Israel
|
0% |
|
Switzerland
|
0% |
|
Netherlands
|
0% |
| Name | Asset class | Sector | Location | Weight |
|---|---|---|---|---|
|
V
Vertex Pharmaceuticals Inc
US92532F1003
|
Equity | Health Care | United States | 7.56% |
|
G
Gilead Sciences Inc
US3755581036
|
Equity | Health Care | United States | 7.47% |
|
A
Amgen Inc
US0311621009
|
Equity | Health Care | United States | 7.36% |
|
R
Regeneron Pharmaceuticals Inc
US75886F1075
|
Equity | Health Care | United States | 6.69% |
|
M
Moderna Inc
US60770K1079
|
Equity | Health Care | United States | 5.96% |
|
A
AstraZeneca PLC ADR
US0463531089
|
Equity | Health Care | United Kingdom | 3.86% |
|
S
Seagen Inc
US81181C1045
|
Equity | Health Care | United States | 3.39% |
|
B
Biogen Inc
US09062X1037
|
Equity | Health Care | United States | 3.24% |
|
I
Illumina Inc
US4523271090
|
Equity | Health Care | United States | 3.12% |
|
H
Horizon Pharma PLC
IE00BQPVQZ61
|
Equity | Health Care | United States | 2.03% |
| Ex-date | Record date | Payment date | Dividend per share |
|---|---|---|---|
| 2022-06-16 | 2022-06-17 | 2022-06-29 | $0.02 |
| 2021-12-16 | 2021-12-17 | 2021-12-31 | $0.01 |
| 2021-06-17 | 2021-06-18 | 2021-06-30 | $0.01 |
| 2020-12-10 | 2020-12-11 | 2020-12-23 | $0.00 |
| 2020-06-11 | 2020-06-12 | 2020-06-24 | $0.01 |
| 2019-12-12 | 2019-12-13 | 2019-12-27 | $0.00 |
| 2019-06-13 | 2019-06-14 | 2019-06-26 | $0.00 |
| 2018-12-13 | 2018-12-14 | 2018-12-28 | $0.00 |
| 2018-06-14 | 2018-06-15 | 2018-06-27 | $0.00 |
| Ticker | MIC | Currency |
|---|---|---|
| BTEE | XLON | USD |